HUIZINGA TW[au] - Search Results

Year	Number of Results
1988	1
1989	3
1990	10
1991	2
1992	3
1993	1
1994	1
1995	1
1996	6
1997	5
1998	9
1999	9
2000	13
2001	19
2002	18
2003	27
2004	33
2005	32
2006	36
2007	41
2008	41
2009	51
2010	73
2011	62
2012	51
2013	85
2014	61
2015	69
2016	54
2017	42
2018	27
2019	32
2020	30
2021	29
2022	34
2023	26
2024	17

1

Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus.

van der Meulen S, Monahan RC, Gelderman KA, van Kooten C, Teng YKO, Huizinga TWJ, Steup-Beekman GM, Trouw LA. van der Meulen S, et al. Among authors: huizinga twj. Eur J Immunol. 2024 Aug 20:e2450998. doi: 10.1002/eji.202450998. Online ahead of print. Eur J Immunol. 2024. PMID: 39165045

2

Acetylated bacterial proteins as potent antigens inducing an anti-modified protein antibody response.

Volkov M, Kampstra ASB, van Schie KAJ, van Mourik AG, Kwekkeboom JC, de Ru A, van Veelen PA, Huizinga TWJ, Toes REM, van der Woude D. Volkov M, et al. Among authors: huizinga twj. RMD Open. 2024 Jul 22;10(3):e004411. doi: 10.1136/rmdopen-2024-004411. RMD Open. 2024. PMID: 39038910 Free PMC article.

3

Infliximab biosimilar GP1111: a review of 5 years' post-approval experience.

Huizinga TWJ, Dipasquale V, Zabransky M, Heyn J, Romano C. Huizinga TWJ, et al. Expert Opin Biol Ther. 2024 Jul;24(7):615-625. doi: 10.1080/14712598.2024.2377298. Epub 2024 Jul 27. Expert Opin Biol Ther. 2024. PMID: 38976286 Review.

4

Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study.

Taylor PC, Schett G, Huizinga TW, Wang Q, Ibrahim F, Zhou B, Liva SG, Shaik JSB, Xiong Y, Leu JH, Panchakshari RA, Loza MJ, Ma K, Dhatt H, Rojo Cella R, Karyekar CS, Cuff CA, Gao S, Fei K. Taylor PC, et al. Among authors: huizinga tw. RMD Open. 2024 Jun 28;10(2):e004278. doi: 10.1136/rmdopen-2024-004278. RMD Open. 2024. PMID: 38942592 Free PMC article. Clinical Trial.

5

Are poor prognostic factors a realistic basis for treatment decisions in patients with rheumatoid arthritis? Lessons from the IMPROVED study.

van der Pol JA, Allaart CF, Huizinga TWJ, Bergstra SA. van der Pol JA, et al. Among authors: huizinga twj. RMD Open. 2024 Jun 21;10(2):e004382. doi: 10.1136/rmdopen-2024-004382. RMD Open. 2024. PMID: 38906542 Free PMC article. No abstract available.

6

Detection of Systemic Sclerosis-associated Interstitial Lung Disease by Exhaled Breath Analysis Using Electronic Nose Technology.

Marges ER, van der Sar IG, de Vries-Bouwstra JK, Huizinga TWJ, van Daele PLA, Wijsenbeek MS, Moor CC, Geelhoed JJM. Marges ER, et al. Among authors: huizinga twj. Am J Respir Crit Care Med. 2024 Aug 15;210(4):512-514. doi: 10.1164/rccm.202402-0272LE. Am J Respir Crit Care Med. 2024. PMID: 38843104 No abstract available.

7

Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.

Ciaffi J, Liem SIE, Cannegieter S, Ahmed S, Hoekstra EM, Wiland P, Atsumi T, Szücs G, Balbir Gurman A, Czirják L, Zanatta E, Koetter I, Henes JC, Matucci-Cerinic M, Airò P, Ursini F, Huizinga TWJ, De Vries-Bouwstra J, Collaborators E. Ciaffi J, et al. Among authors: huizinga twj. RMD Open. 2024 May 20;10(2):e004101. doi: 10.1136/rmdopen-2024-004101. RMD Open. 2024. PMID: 38772679 Free PMC article.

8

Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study.

van der Pol JA, Allaart CF, Lems W, van der Kooij SM, Huizinga TWJ, Bergstra SA. van der Pol JA, et al. Among authors: huizinga twj. RMD Open. 2024 Apr 30;10(2):e004246. doi: 10.1136/rmdopen-2024-004246. RMD Open. 2024. PMID: 38688692 Free PMC article. Clinical Trial.

9

Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis.

Stork EM, van Rijswijck DMH, van Schie KA, Hoek M, Kissel T, Scherer HU, Huizinga TWJ, Heck AJR, Toes REM, Bondt A. Stork EM, et al. Among authors: huizinga twj. Nat Commun. 2024 Apr 10;15(1):3114. doi: 10.1038/s41467-024-47337-x. Nat Commun. 2024. PMID: 38600082 Free PMC article.

10

Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies.

Heckert SL, Maassen JM, Nevins I, Baudoin P, Steup-Beekman GM, Huizinga TWJ, Bergstra SA, Allaart CF. Heckert SL, et al. Among authors: huizinga twj. Rheumatology (Oxford). 2024 Apr 1:keae212. doi: 10.1093/rheumatology/keae212. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38561181

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

905 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

905 results

Results by year